Skip to content

Clinical trials

Phase 3 Obesity trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 3 Country / region: Canada Clear all

88 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20042
20053
20063
20081
20112
20123
20151
20173
20187
20215
20225
202310
20242
202516
202621

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38
Recruiting23
Active, not recruiting17
Terminated7
Not yet recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S28
Eli Lilly and Company16
Amgen8
Sanofi7
Pfizer5
Rhythm Pharmaceuticals, Inc.4
AstraZeneca3
Boehringer Ingelheim3
Hoffmann-La Roche2
Ascletis Pharma (China) Co., Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity88
Overweight40
Diabetes Mellitus, Type 215
Nutrition Disorders9
Sleep Apnea, Obstructive5
Dyslipidemias4
Body Weight3
Diabetes Mellitus3
Osteoarthritis, Knee3
Overnutrition3

Trials

Showing 1 to 25 of 88. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.